Cargando…
Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction
BACKGROUND: Diagnostic value of fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT) in the assessment of myocardial viable segments is well known; hence, it can identify patients with left ventricular (LV) systolic dysfunction who may benefit from revascu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348504/ https://www.ncbi.nlm.nih.gov/pubmed/37456177 http://dx.doi.org/10.4103/ijnm.ijnm_74_22 |
_version_ | 1785073678958985216 |
---|---|
author | Thangamuthu, Brithika Yoganayaki Elangovan, Indirani Asra, Patel Simon, Shelley Sathyamoorthy, Immaneni |
author_facet | Thangamuthu, Brithika Yoganayaki Elangovan, Indirani Asra, Patel Simon, Shelley Sathyamoorthy, Immaneni |
author_sort | Thangamuthu, Brithika Yoganayaki |
collection | PubMed |
description | BACKGROUND: Diagnostic value of fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT) in the assessment of myocardial viable segments is well known; hence, it can identify patients with left ventricular (LV) systolic dysfunction who may benefit from revascularization. The presence of significant myocardial viable segments before revascularization will offer better prognosis with reduced mortality and morbidity. However, the usage of F18-FDG PET/CT myocardial viability study in the presurgical risk stratification is limited. OBJECTIVE: The objective of the study is to predict perioperative mortality with hibernating viable myocardial (HVM) segments established by F18-FDG PET/CT in comparison with EuroSCORE II in patients with LV dysfunction undergoing coronary artery bypass grafting surgery. MATERIALS AND METHODS: A prospective, observational study included 75 patients of chronic ischemic coronary artery disease with ejection fraction ≤40%. Tc-99m sesta-methoxyisobutylisonitrile myocardial perfusion single photon emission CT/CT and myocardial viability with F18-FDG PET/CT at rest were performed. Mortality risk stratification was done according to the EuroSCORE II. Patients were followed for post-coronary artery bypass graft surgery (CABG) 30-day mortality. Mortality observed by HVM segment groups were compared with EuroSCORE II predicted mortality. RESULTS: Receiver operating curve for 30-day mortality prediction with HVM segments and EuroSCORE II was constructed. It showed that a cutoff of <4 HVM segments (area under the curve [AUC] = 0.7) had a sensitivity of 85%, whereas EuroSCORE II (AUC = 0.4) had only 28.6% sensitivity. EuroSCORE II underestimated perioperative risk in patients with <4 viable segments, that is 5 times higher risk was observed in patients with <4 viable segments. CONCLUSIONS: HVM segments established by F18-FDG PET/CT had independently predicted mortality postoperatively. Hence, including F18-FDG PET/CT for viability assessment along with EuroSCORE II in preoperative risk assessment for revascularization by CABG in patients with LV dysfunction provided better risk stratification. |
format | Online Article Text |
id | pubmed-10348504 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-103485042023-07-15 Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction Thangamuthu, Brithika Yoganayaki Elangovan, Indirani Asra, Patel Simon, Shelley Sathyamoorthy, Immaneni Indian J Nucl Med Original Article BACKGROUND: Diagnostic value of fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT) in the assessment of myocardial viable segments is well known; hence, it can identify patients with left ventricular (LV) systolic dysfunction who may benefit from revascularization. The presence of significant myocardial viable segments before revascularization will offer better prognosis with reduced mortality and morbidity. However, the usage of F18-FDG PET/CT myocardial viability study in the presurgical risk stratification is limited. OBJECTIVE: The objective of the study is to predict perioperative mortality with hibernating viable myocardial (HVM) segments established by F18-FDG PET/CT in comparison with EuroSCORE II in patients with LV dysfunction undergoing coronary artery bypass grafting surgery. MATERIALS AND METHODS: A prospective, observational study included 75 patients of chronic ischemic coronary artery disease with ejection fraction ≤40%. Tc-99m sesta-methoxyisobutylisonitrile myocardial perfusion single photon emission CT/CT and myocardial viability with F18-FDG PET/CT at rest were performed. Mortality risk stratification was done according to the EuroSCORE II. Patients were followed for post-coronary artery bypass graft surgery (CABG) 30-day mortality. Mortality observed by HVM segment groups were compared with EuroSCORE II predicted mortality. RESULTS: Receiver operating curve for 30-day mortality prediction with HVM segments and EuroSCORE II was constructed. It showed that a cutoff of <4 HVM segments (area under the curve [AUC] = 0.7) had a sensitivity of 85%, whereas EuroSCORE II (AUC = 0.4) had only 28.6% sensitivity. EuroSCORE II underestimated perioperative risk in patients with <4 viable segments, that is 5 times higher risk was observed in patients with <4 viable segments. CONCLUSIONS: HVM segments established by F18-FDG PET/CT had independently predicted mortality postoperatively. Hence, including F18-FDG PET/CT for viability assessment along with EuroSCORE II in preoperative risk assessment for revascularization by CABG in patients with LV dysfunction provided better risk stratification. Wolters Kluwer - Medknow 2023 2023-06-08 /pmc/articles/PMC10348504/ /pubmed/37456177 http://dx.doi.org/10.4103/ijnm.ijnm_74_22 Text en Copyright: © 2023 Indian Journal of Nuclear Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Thangamuthu, Brithika Yoganayaki Elangovan, Indirani Asra, Patel Simon, Shelley Sathyamoorthy, Immaneni Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction |
title | Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction |
title_full | Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction |
title_fullStr | Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction |
title_full_unstemmed | Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction |
title_short | Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction |
title_sort | fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography cardiac viability risk stratification in comparison with euroscore ii for revascularization in patients with left ventricular dysfunction |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348504/ https://www.ncbi.nlm.nih.gov/pubmed/37456177 http://dx.doi.org/10.4103/ijnm.ijnm_74_22 |
work_keys_str_mv | AT thangamuthubrithikayoganayaki fluorine18fluorodeoxyglucosepositronemissiontomographycomputedtomographycardiacviabilityriskstratificationincomparisonwitheuroscoreiiforrevascularizationinpatientswithleftventriculardysfunction AT elangovanindirani fluorine18fluorodeoxyglucosepositronemissiontomographycomputedtomographycardiacviabilityriskstratificationincomparisonwitheuroscoreiiforrevascularizationinpatientswithleftventriculardysfunction AT asrapatel fluorine18fluorodeoxyglucosepositronemissiontomographycomputedtomographycardiacviabilityriskstratificationincomparisonwitheuroscoreiiforrevascularizationinpatientswithleftventriculardysfunction AT simonshelley fluorine18fluorodeoxyglucosepositronemissiontomographycomputedtomographycardiacviabilityriskstratificationincomparisonwitheuroscoreiiforrevascularizationinpatientswithleftventriculardysfunction AT sathyamoorthyimmaneni fluorine18fluorodeoxyglucosepositronemissiontomographycomputedtomographycardiacviabilityriskstratificationincomparisonwitheuroscoreiiforrevascularizationinpatientswithleftventriculardysfunction |